小林製薬(株)の貸借残高情報
主市場 | 業種 | 証券コード/EDINET | 英名称 |
---|
東証PRM | 化学 | 4967/E01047 | - |
公表日 | 公表 | 貸付残高 | 前週比 | 新規貸付成約高 | 前週比 | 借入残高 | 前週比 | 新規借入成約高 | 前週比 |
---|
2014/12/12 | 日証協 | 686,683株 | -5.25% | 234,611株 | +186.65% | 656,619株 | -1.68% | 94,647株 | +212.05% |
2014/12/05 | 日証協 | 724,712株 | -4.39% | 81,846株 | -62.64% | 667,872株 | -1.53% | 30,331株 | +32.39% |
2014/11/28 | 日証協 | 757,970株 | +2.01% | 219,089株 | +172.88% | 678,241株 | -1.6% | 22,911株 | -28.08% |
2014/11/21 | 日証協 | 743,027株 | -0.02% | 80,289株 | -68.47% | 689,297株 | -5.4% | 31,856株 | -36.88% |
2014/11/14 | 日証協 | 743,168株 | +1.22% | 254,628株 | +115.27% | 728,641株 | -0.36% | 50,470株 | -21.33% |
2014/11/07 | 日証協 | 734,211株 | +8.55% | 118,281株 | +345.4% | 731,271株 | +7.83% | 64,156株 | +116.41% |
2014/10/31 | 日証協 | 676,368株 | -0.83% | 26,556株 | -86.51% | 678,174株 | -1.19% | 29,645株 | -19.69% |
2014/10/24 | 日証協 | 682,001株 | -0.57% | 196,890株 | -4.22% | 686,324株 | +2.55% | 36,912株 | +87.9% |
2014/10/17 | 日証協 | 685,901株 | +7.53% | 205,571株 | +67.81% | 669,231株 | -2.17% | 19,644株 | -54.24% |
2014/10/10 | 日証協 | 637,881株 | +3.26% | 122,503株 | -44.95% | 684,087株 | -0.04% | 42,930株 | -31.84% |
2014/10/03 | 日証協 | 617,758株 | +4.33% | 222,512株 | +35.43% | 684,357株 | +5.13% | 62,984株 | -63.96% |
2014/09/26 | 日証協 | 592,107株 | +4.65% | 164,296株 | +68.11% | 650,991株 | +9.8% | 174,772株 | +273.8% |
2014/09/19 | 日証協 | 565,777株 | +0.93% | 97,732株 | +5.3% | 592,894株 | +0.52% | 46,756株 | +156.1% |
2014/09/12 | 日証協 | 560,589株 | -5.6% | 92,814株 | +29.44% | 589,850株 | -6.11% | 18,257株 | -71.2% |
2014/09/05 | 日証協 | 593,851株 | +0.49% | 71,707株 | -33.24% | 628,238株 | +1.87% | 63,400株 | +150.16% |
2014/08/29 | 日証協 | 590,929株 | -6.73% | 107,418株 | +74.95% | 616,717株 | -0.86% | 25,344株 | -55.77% |
2014/08/22 | 日証協 | 633,583株 | +1.29% | 61,398株 | -42.44% | 622,095株 | +3.25% | 57,300株 | +120.22% |
2014/08/15 | 日証協 | 625,483株 | -3.03% | 106,662株 | -27.67% | 602,495株 | -4.07% | 26,020株 | -62.83% |
2014/08/08 | 日証協 | 645,006株 | -5.52% | 147,463株 | -16.78% | 628,075株 | -4.33% | 70,001株 | +21.53% |
※株式分割は考慮していませんのでご注意ください。
Page Top